Primary |
Hepatitis C |
53.7% |
Product Used For Unknown Indication |
24.6% |
Drug Use For Unknown Indication |
13.7% |
Chronic Hepatitis C |
2.3% |
Diabetes Mellitus |
2.3% |
Hepatitis |
2.3% |
Gastritis |
0.6% |
Rheumatoid Arthritis |
0.6% |
|
Weight Decreased |
14.5% |
White Blood Cell Count Decreased |
14.5% |
Pregnancy Of Partner |
9.1% |
Loss Of Consciousness |
7.3% |
Vomiting |
7.3% |
Rash |
5.5% |
Stomatitis |
5.5% |
Anaemia |
3.6% |
Dyspnoea |
3.6% |
Haemoglobin Decreased |
3.6% |
Palpitations |
3.6% |
Pancytopenia |
3.6% |
Red Blood Cell Count Decreased |
3.6% |
Suicidal Ideation |
3.6% |
Blood Count Abnormal |
1.8% |
Blood Creatinine Increased |
1.8% |
Chest Pain |
1.8% |
Confusional State |
1.8% |
Crying |
1.8% |
Death |
1.8% |
|
Secondary |
Hepatitis C |
82.2% |
Product Used For Unknown Indication |
3.4% |
Hypertension |
3.1% |
Chronic Hepatitis C |
2.8% |
Hepatitis |
1.8% |
Hiv Infection |
0.9% |
Anaemia |
0.6% |
Bipolar Disorder |
0.6% |
Hyperthyroidism |
0.6% |
Infection |
0.6% |
Insomnia |
0.6% |
Anxiety |
0.3% |
Asthma |
0.3% |
Attention Deficit/hyperactivity Disorder |
0.3% |
Avian Influenza |
0.3% |
Blood Cholesterol Increased |
0.3% |
Depression |
0.3% |
Diarrhoea |
0.3% |
Dyspepsia |
0.3% |
Gastritis |
0.3% |
|
White Blood Cell Count Decreased |
23.6% |
Thrombocytopenia |
8.3% |
Rash |
6.9% |
Fatigue |
5.6% |
Weight Decreased |
5.6% |
Cardiac Failure |
4.2% |
Dizziness |
4.2% |
Pharyngeal Mass |
4.2% |
Rash Macular |
4.2% |
Spinal Operation |
4.2% |
Visual Impairment |
4.2% |
Abdominal Discomfort |
2.8% |
Chronic Obstructive Pulmonary Disease |
2.8% |
Depression |
2.8% |
Heart Rate Decreased |
2.8% |
Joint Swelling |
2.8% |
Medication Error |
2.8% |
No Therapeutic Response |
2.8% |
Obstruction |
2.8% |
Peritonitis |
2.8% |
|
Concomitant |
Hepatitis C |
77.5% |
Product Used For Unknown Indication |
4.2% |
Imaging Procedure |
3.3% |
Acute Myeloid Leukemia Nos |
2.5% |
Bipolar Disorder |
2.5% |
Ankylosing Spondylitis |
1.7% |
Osteoporotic Fracture |
1.7% |
Wheezing |
1.7% |
Drug Use For Unknown Indication |
0.8% |
Ill-defined Disorder |
0.8% |
Myasthenia Gravis |
0.8% |
Nuclear Magnetic Resonance Imaging Abdominal |
0.8% |
Nuclear Magnetic Resonance Imaging Brain |
0.8% |
Prophylaxis |
0.8% |
|
Orthostatic Hypotension |
13.9% |
Blood Creatinine Increased |
11.1% |
Anaemia |
8.3% |
Skin Disorder |
8.3% |
Glucose-6-phosphate Dehydrogenase Deficiency |
5.6% |
Limb Discomfort |
5.6% |
Platelet Count Decreased |
5.6% |
Pneumonia |
5.6% |
Rash |
5.6% |
Abdominal Distension |
2.8% |
Cardiac Discomfort |
2.8% |
Drug Rash With Eosinophilia And Systemic Symptoms |
2.8% |
Epilepsy |
2.8% |
Gastrointestinal Oedema |
2.8% |
Haemoglobin Decreased |
2.8% |
Headache |
2.8% |
Hepatic Cirrhosis |
2.8% |
Hepatobiliary Disease |
2.8% |
Hyperthyroidism |
2.8% |
Impaired Healing |
2.8% |
|